Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Low-Dose CBCT AI Model for Interventions

Official title: Low-dose AI-reconstructed CBCT Versus Full-dose CBCT for Guidance of Interventional Procedures: a Multicenter Randomized Controlled Trial

Run by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · NCT07845929 · Data updated 2026-11-12

This trial tests a low-dose CBCT AI model to guide image-guided interventional procedures for adults requiring CBCT during brain, lung, or liver interventions.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1380 (estimated)
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Academic / other
Drugs / interventionsradiation
Locations5 sites (Hefei, Anhui and 4 other locations)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedNovember 30, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 29, 2026
Trial IDNCT07845929 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older undergoing CBCT-guided interventional procedures (brain, lung, or liver) who can provide informed consent.

Probably not a fit

Patients unlikely to benefit include those not undergoing CBCT-guided interventions or with conditions incompatible with the low-dose protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study compares a DeepPriorCBCT-V2 AI-assisted low-dose cone-beam CT protocol with the standard full-dose CBCT used in interventional procedures. It leverages a pre-trained neural model to preserve image quality while reducing radiation exposure. Eligible participants are adults needing CBCT-guided interventions such as cerebral angiography, lung biopsies, or liver procedures. The trial collects imaging data to assess whether the AI model maintains diagnostic and procedural adequacy at reduced radiation. Safety monitoring and informed consent are integral components of the protocol.

Why it matters

Potential benefit: If successful, patients could receive similar diagnostic and procedural quality with substantially lower radiation exposure.

How similar studies have gone: Previous work with DeepPriorCBCT and related AI-enhanced dosing has shown promise in maintaining image quality at reduced doses in thoracic imaging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.

  * Requires CBCT-guided interventional treatment or surgery (e.g., cerebral angiography, lung puncture biopsy, hepatic artery chemoembolization, or percutaneous liver biopsy) and meets operational indications.

    * Can understand the study's purpose, procedures, potential risks, and benefits, and voluntarily signs a written informed consent form.

Exclusion Criteria:

* History of high-dose radiation exams or treatments.

  * Known allergies or severe adverse reactions to iodine contrast agents or other relevant medications.

    * Pregnant or breastfeeding women.

      * Severe comorbidities or chronic diseases (e.g., severe diabetes, renal insufficiency).

        * Severe mental illness or cognitive impairment preventing understanding of the study procedures or providing informed consent.

          ⑥ Participants are not suitable for the trial per investigator's opinion.

Where it's running

  • The First Affiliated Hospital of University of Science and Technology of China
    Hefei, Anhui, China
    Recruiting
  • Wuhan Union Hospital
    Wuhan, Hubei, China
    Recruiting
  • Wuhan Union Jinyin Lake Hospital
    Wuhan, Hubei, China
    Recruiting
  • Wuhan Union West Hospital
    Wuhan, Hubei, China
    Recruiting
  • Zhongda Hospital, Medical School, Southeast University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.